Skip to content

U-100 unit conversion

CerebroNeurogen calculator

Convert mass and volume to U-100 units. No dose is selected.

These are example numbers so you can see the math. Try yours. Change them to match the vial in your hand.

5U-100 units · 0.05 mL

50 mcg per unit · 5000 mcg/mL

How the calculator works, sources and review dates

CerebroNeurogen math uses the listed vial sizes on this card and the liquid you type. Concentration in mcg per mL is vial milligrams times 1000, divided by milliliters. A U-100 syringe has 100 marks per milliliter, so each unit is that concentration divided by 100. Example numbers so you can see the math: a 10 mg listing plus 2 mL of liquid. Change any number and the units change. Try the numbers. A research-market vial is not the same material used in a trial.

Editorial review 2026-10-10. source-curated; clinician review pending.

Units chart for listed CerebroNeurogen sizes

This card has no units chart until a milligram size is listed.

What is CerebroNeurogen?

Other names in the library: CerebroNeurogen — 10ml (Out of stock), CerebroNeurogen — 2ml, CerebroNeurogen — 5ml. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: no listed milligram sizes in the vendor file. A seller title is a listing. It does not prove the vial matches a paper.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Regulatory context

Regulatory context; not efficacy evidence

No matched controlled clinical study of this exact preparation was verified in this source audit.

Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.

Nonresponse. Nonresponse frequency not established in this excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Related-compound evidence is contextual only. Commercial names, modifications and routes do not establish clinical equivalence.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human trial

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.

CARS exploratory randomized double-blind trial: 208 stroke patients randomized; 205 in primary efficacy analysis.

Reported findings. Day 90 arm-function changes were 30.7 versus 15.9 ARAT points. Unitless Mann–Whitney arm-function effect estimator 0.71, CI 0.63–0.79; not a population success rate.

Nonresponse. No observed neglect benefit; few affected participants.

Harms. Adverse events 69.2% versus 71.2%; serious events 3 versus 7, investigators judged unrelated. Active-arm serious events included peripheral ischemia, renal colic and myocardial infarction.

Limits. Exploratory study and rehabilitation co-intervention limit generalization. Supplier porcine-mixture/FPF1070 identity assertion does not verify catalog-stock equivalence.

Preparation: Standardized porcine Cerebrolysin; vendor CerebroNeurogen/FPF1070 equivalence unverified. Route: Intravenous alongside rehabilitation.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human trial

Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.

CASTA: 1070 acute ischemic stroke patients randomized double-blind.

Reported findings. Severe-stroke subgroup signals were post hoc, not the primary endpoint.

Nonresponse. No significant primary composite-endpoint difference.

Harms. Full outcome-paper adverse-event details unverified in accessible abstract; safety not inferred.

Limits. Post hoc subgroup findings do not supersede neutral primary endpoint. Full outcome-paper methods, funding and conflict disclosures unverified; publisher access failed.

Preparation: Medicinal Cerebrolysin; catalog CerebroNeurogen equivalence unverified. Route: Intravenous alongside aspirin; not isolated research-market mixture.

Read original source ↗

Editorial review 2026-10-10. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Compounding

not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.

Research

source limited. No matched controlled clinical study of this exact preparation was verified in this source audit.

Sport

unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.

Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.

Risks and mix-ups already on the record

  • Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
  • No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
  • No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.

People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.

Sources

  1. Regulatory context; not efficacy evidence · checked 2026-10-09

Questions people ask

Is CerebroNeurogen FDA-approved?

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Does PepBear pick an amount of CerebroNeurogen?

The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.

How many units is a listed CerebroNeurogen vial after you add water?

Units = (amount in mcg ÷ (vial mg × 1000 ÷ water mL)) × 100 on a U-100 syringe. Enter the three numbers. The chart shows the same math for each listed vial size and 1, 2 or 3 mL of liquid.

Why flag amounts under 5 units?

A U-100 barrel is easy to misread below about 5 marks. That is a measuring warning. The page does not tell you to take more.

Related cards

Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.